Tarsus Pharmaceuticals, Inc. TARS Shares Reserved for Future Issuance Under Stock Plans
Shares Reserved for Future Issuance Under Stock Plans at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockCapitalSharesReservedForFutureIssuance.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s shares reserved for future issuance under stock plans.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s shares reserved for future issuance under stock plans?
- Tarsus Pharmaceuticals, Inc. (TARS) reported shares reserved for future issuance under stock plans of 19.5M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s shares reserved for future issuance under stock plans changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s shares reserved for future issuance under stock plans increased by 6.0% year-over-year, from 18.4M to 19.5M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s shares reserved for future issuance under stock plans?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s shares reserved for future issuance under stock plans has grown at a 9.7% compound annual growth rate (CAGR), from 11.3M to 17.9M.
- What does shares reserved for future issuance under stock plans mean?
- This represents the total number of common shares authorized and set aside for future issuance to employees and directors under equity compensation plans. It provides insight into the potential future dilution of existing shareholders. Investors monitor this to assess the firm's long-term incentive structure.